{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T01:13:19Z","timestamp":1788484399365,"version":"build-2803163510"},"reference-count":68,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.revmed.2026.06.013","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T20:11:43Z","timestamp":1783714303000},"page":"483-489","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Revue de la litt\u00e9rature des effets cliniques immunomodulateurs des cannabino\u00efdes au cours des maladies auto-immunes en m\u00e9decine interne"],"prefix":"10.1016","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-1361-8545","authenticated-orcid":false,"given":"Jean-Guillaume","family":"Lopez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2026.06.013_bib0345","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jep.2018.09.004","article-title":"Cannabis sativa: a comprehensive ethnopharmacological review of a medicinal plant with a long history","volume":"227","author":"Bonini","year":"2018","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.revmed.2026.06.013_bib0350","doi-asserted-by":"crossref","first-page":"4552","DOI":"10.1021\/ja00993a072","article-title":"A stereospecific synthesis of (-)-delta 1- and (-)-delta 1(6)-tetrahydrocannabinols","volume":"89","author":"Mechoulam","year":"1967","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.revmed.2026.06.013_bib0355","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1002\/cbdv.200790144","article-title":"History of cannabis and its preparations in saga, science, and sobriquet","volume":"4","author":"Russo","year":"2007","journal-title":"Chem Biodivers"},{"key":"10.1016\/j.revmed.2026.06.013_bib0360","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0014-2999(98)00392-6","article-title":"An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity","volume":"353","author":"Ben-Shabat","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.revmed.2026.06.013_bib0365","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1111\/j.1476-5381.2011.01238.x","article-title":"Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects","volume":"163","author":"Russo","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.revmed.2026.06.013_bib0370","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0306-4522(96)00428-9","article-title":"Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain","volume":"77","author":"Glass","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.revmed.2026.06.013_bib0375","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/365061a0","article-title":"Molecular characterization of a peripheral receptor for cannabinoids","volume":"365","author":"Munro","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.revmed.2026.06.013_bib0380","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1124\/pr.54.2.161","article-title":"International Union of Pharmacology. XXVII. Classification of cannabinoid receptors","volume":"54","author":"Howlett","year":"2002","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.revmed.2026.06.013_bib0385","doi-asserted-by":"crossref","first-page":"R43","DOI":"10.1186\/ar2401","article-title":"Characterisation of the cannabinoid receptor system in synovial tissue and fluid in patients with osteoarthritis and rheumatoid arthritis","volume":"10","author":"Richardson","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.revmed.2026.06.013_bib0390","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1089\/can.2017.0059","article-title":"Medicinal cannabis on prescription in The Netherlands: statistics for 2003\u20132016","volume":"3","author":"de Hoop","year":"2018","journal-title":"Cannabis Cannabinoid Res"},{"key":"10.1016\/j.revmed.2026.06.013_bib0395","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s10900-021-01049-1","article-title":"Self-reported medical and nonmedical cannabis use: results from the 2018 Behavioral Risk Factor Surveillance System in 14 States","volume":"47","author":"Schauer","year":"2022","journal-title":"J Community Health"},{"key":"10.1016\/j.revmed.2026.06.013_bib0400","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1742-1241.2004.00271.x","article-title":"The medicinal use of cannabis in the UK: results of a nationwide survey","volume":"59","author":"Ware","year":"2005","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.revmed.2026.06.013_bib0405","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1007\/s00228-013-1503-y","article-title":"The prevalence and incidence of medicinal cannabis on prescription in The Netherlands","volume":"69","author":"Hazekamp","year":"2013","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.revmed.2026.06.013_bib0410","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1089\/can.2018.0006","article-title":"A cross-sectional study of cannabidiol users","volume":"3","author":"Corroon","year":"2018","journal-title":"Cannabis Cannabinoid Res"},{"key":"10.1016\/j.revmed.2026.06.013_bib0415","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1002\/acr.24752","article-title":"Increase in Cannabis use among adults with rheumatic diseases: results from a 2014\u20132019 United States Observational Study","volume":"74","author":"Wipfler","year":"2022","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.revmed.2026.06.013_bib0420","doi-asserted-by":"crossref","first-page":"105633","DOI":"10.1016\/j.jpain.2025.105633","article-title":"Pharmacoepidemiologic characterization of cannabis use and symptomatology in rheumatology using natural language processing of electronic health record clinic notes","volume":"39","author":"Falasinnu","year":"2025","journal-title":"J Pain"},{"key":"10.1016\/j.revmed.2026.06.013_bib0425","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1152\/physrev.00002.2016","article-title":"From phytocannabinoids to cannabinoid receptors and endocannabinoids: pleiotropic physiological and pathological roles through complex pharmacology","volume":"96","author":"Ligresti","year":"2016","journal-title":"Physiol Rev"},{"key":"10.1016\/j.revmed.2026.06.013_bib0430","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1189\/jlb.3RU0115-021R","article-title":"Regulation of inflammation by cannabinoids, the endocannabinoids 2-arachidonoyl-glycerol and arachidonoyl-ethanolamide, and their metabolites","volume":"97","author":"Turcotte","year":"2015","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.revmed.2026.06.013_bib0435","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0014-2999(97)01007-8","article-title":"Influence of fatty acid ethanolamides and delta9-tetrahydrocannabinol on cytokine and arachidonate release by mononuclear cells","volume":"330","author":"Berdyshev","year":"1997","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"10.1016\/j.revmed.2026.06.013_bib0440","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/imm.13378","article-title":"Endocannabinoids in immune regulation and immunopathologies","volume":"164","author":"Rahaman","year":"2021","journal-title":"Immunology"},{"key":"10.1016\/j.revmed.2026.06.013_bib0445","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.4049\/jimmunol.1002853","article-title":"The endocannabinoid 2-arachidonoyl-glycerol activates human neutrophils: critical role of its hydrolysis and de novo leukotriene B4 biosynthesis","volume":"186","author":"Chouinard","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.revmed.2026.06.013_bib0450","doi-asserted-by":"crossref","first-page":"5899","DOI":"10.1021\/cr2002799","article-title":"Endocannabinoid oxygenation by cyclooxygenases, lipoxygenases, and cytochromes P450: cross-talk between the eicosanoid and endocannabinoid signaling pathways","volume":"111","author":"Rouzer","year":"2011","journal-title":"Chem Rev"},{"key":"10.1016\/j.revmed.2026.06.013_bib0455","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11481-007-9077-z","article-title":"The cannabinoid delta-9-tetrahydrocannabinol mediates inhibition of macrophage chemotaxis to RANTES\/CCL5: linkage to the CB2 receptor","volume":"3","author":"Raborn","year":"2008","journal-title":"J Neuroimmune Pharmacol"},{"key":"10.1016\/j.revmed.2026.06.013_bib0460","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nrn3846","article-title":"Programming of neural cells by (endo)cannabinoids: from physiological rules to emerging therapies","volume":"15","author":"Maccarrone","year":"2014","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.revmed.2026.06.013_bib0465","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/28393","article-title":"Control of pain initiation by endogenous cannabinoids","volume":"394","author":"Calignano","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.revmed.2026.06.013_bib0470","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/sj.bjp.0704767","article-title":"Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol","volume":"136","author":"Kirkham","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.revmed.2026.06.013_bib0475","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/hipo.22272","article-title":"Elevation of endogenous anandamide impairs LTP, learning, and memory through CB1 receptor signaling in mice","volume":"24","author":"Basavarajappa","year":"2014","journal-title":"Hippocampus"},{"key":"10.1016\/j.revmed.2026.06.013_bib0480","doi-asserted-by":"crossref","first-page":"7642","DOI":"10.1038\/srep07642","article-title":"Selective blockade of the hydrolysis of the endocannabinoid 2-arachidonoylglycerol impairs learning and memory performance while producing antinociceptive activity in rodents","volume":"5","author":"Griebel","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.revmed.2026.06.013_bib0485","doi-asserted-by":"crossref","first-page":"18333","DOI":"10.1073\/pnas.1420285111","article-title":"Endogenous cannabinoid release within prefrontal-limbic pathways affects memory consolidation of emotional training","volume":"111","author":"Morena","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.revmed.2026.06.013_bib0490","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.pbb.2005.01.029","article-title":"Endocannabinoid system and stress and anxiety responses","volume":"81","author":"Viveros","year":"2005","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.revmed.2026.06.013_bib0495","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.tins.2006.01.008","article-title":"Involvement of the endocannabinoid system in drug addiction","volume":"29","author":"Maldonado","year":"2006","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.revmed.2026.06.013_bib0500","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1126\/science.1209200","article-title":"Endocannabinoid hydrolysis generates brain prostaglandins that promote neuroinflammation","volume":"334","author":"Nomura","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.revmed.2026.06.013_bib0505","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/sj.bjp.0704379","article-title":"Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats","volume":"134","author":"Jamshidi","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.revmed.2026.06.013_bib0510","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.tips.2012.03.002","article-title":"At the heart of the matter: the endocannabinoid system in cardiovascular function and dysfunction","volume":"33","author":"Montecucco","year":"2012","journal-title":"Trends Pharmacol Sci"},{"issue":"3","key":"10.1016\/j.revmed.2026.06.013_bib0515","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/imm.12441","article-title":"Endocannabinoid signalling in innate and adaptive immunity","volume":"144","author":"Chiurchi\u00f9","year":"2015","journal-title":"Immunology"},{"key":"10.1016\/j.revmed.2026.06.013_bib0520","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nri1602","article-title":"Cannabinoid-based drugs as anti-inflammatory therapeutics","volume":"5","author":"Klein","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.revmed.2026.06.013_bib0525","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1089\/can.2020.0105","article-title":"The effects of cannabinoids on pro- and anti-inflammatory cytokines: a systematic review of in vivo studies","volume":"6","author":"Henshaw","year":"2021","journal-title":"Cannabis Cannabinoid Res"},{"key":"10.1016\/j.revmed.2026.06.013_bib0530","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/0192-0561(88)90137-3","article-title":"Suppression by delta-9-tetrahydrocannabinol of interleukin 2-induced lymphocyte proliferation and lymphokine-activated killer cell activity","volume":"10","author":"Kawakami","year":"1988","journal-title":"Int J Immunopharmacol"},{"key":"10.1016\/j.revmed.2026.06.013_bib0535","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/S0022-3565(25)09609-0","article-title":"delta 9-Tetrahydrocannabinol modulates antigen processing by macrophages","volume":"273","author":"McCoy","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.revmed.2026.06.013_bib0540","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jneuroim.2003.10.017","article-title":"Mechanisms for impaired effector function in alveolar macrophages from marijuana and cocaine smokers","volume":"147","author":"Roth","year":"2004","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.revmed.2026.06.013_bib0545","doi-asserted-by":"crossref","first-page":"36810","DOI":"10.1074\/jbc.M113.503037","article-title":"Distinct microRNA expression profile and targeted biological pathways in functional myeloid-derived suppressor cells induced by \u03949-tetrahydrocannabinol in vivo: regulation of CCAAT\/enhancer-binding protein \u03b1 by microRNA-690","volume":"288","author":"Hegde","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.revmed.2026.06.013_bib0550","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1126\/science.183.4123.419","article-title":"Inhibition of cellular mediated immunity in marihuana smokers","volume":"183","author":"Nahas","year":"1974","journal-title":"Science"},{"key":"10.1016\/j.revmed.2026.06.013_bib0555","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.drugalcdep.2014.04.011","article-title":"Self-reported lifetime marijuana use and interleukin-6 levels in middle-aged African Americans","volume":"140","author":"Keen","year":"2014","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.revmed.2026.06.013_bib0560","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s10865-015-9625-6","article-title":"Differential effects of self-reported lifetime marijuana use on interleukin-1 alpha and tumor necrosis factor in African American adults","volume":"38","author":"Keen","year":"2015","journal-title":"J Behav Med"},{"key":"10.1016\/j.revmed.2026.06.013_bib0565","first-page":"33","article-title":"Th17\/Treg imbalance in opioids and cannabinoids addiction: relationship to NF-\u03baB activation in CD4+ T cells","volume":"21","author":"Abo-Elnazar","year":"2014","journal-title":"Egypt J Immunol"},{"key":"10.1016\/j.revmed.2026.06.013_bib0570","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s40290-025-00591-w","article-title":"Studies of cannabinoid-based products in ClinicalTrials.gov: a scoping review","volume":"40","author":"Haney","year":"2026","journal-title":"Pharm Med"},{"key":"10.1016\/j.revmed.2026.06.013_bib0575","first-page":"CD013444","article-title":"Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis","volume":"5","author":"Filippini","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.revmed.2026.06.013_bib0580","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.biocel.2018.04.010","article-title":"Endocannabinoid system in systemic lupus erythematosus: first evidence for a deranged 2-arachidonoylglycerol metabolism","volume":"99","author":"Navarini","year":"2018","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.revmed.2026.06.013_bib0585","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1136\/annrheumdis-2013-204909","article-title":"PXK locus in systemic lupus erythematosus: fine mapping and functional analysis reveals novel susceptibility gene ABHD6","volume":"74","author":"Oparina","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2026.06.013_bib0590","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.4049\/jimmunol.1801521","article-title":"Cutting edge: dysregulated endocannabinoid-rheostat for plasmacytoid dendritic cell activation in a systemic lupus endophenotype","volume":"202","author":"Rahaman","year":"2019","journal-title":"J Immunol"},{"key":"10.1016\/j.revmed.2026.06.013_bib0595","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/01.ASW.0000891856.08360.61","article-title":"Topical cannabidiol in the treatment of digital ulcers in patients with scleroderma: comparative analysis and literature review","volume":"36","author":"Spinella","year":"2023","journal-title":"Adv Skin Wound Care"},{"key":"10.1016\/j.revmed.2026.06.013_bib0600","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s42238-025-00342-3","article-title":"Efficacy of cannabis oil on appetite and quality of life in systemic sclerosis patients: a randomized placebo-controlled trial","volume":"7","author":"Pisprasert","year":"2025","journal-title":"J Cannabis Res"},{"key":"10.1016\/j.revmed.2026.06.013_bib0605","first-page":"727","article-title":"Efficacy of cannabis oil in improving subjective sleep quality in systemic sclerosis: a prospective placebo-controlled study","volume":"15","author":"So-Ngern","year":"2025","journal-title":"Life (Basel)"},{"key":"10.1016\/j.revmed.2026.06.013_bib0610","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1016\/j.jid.2017.05.035","article-title":"Cannabinoid reduces inflammatory cytokines, tumor necrosis factor-\u03b1, and type I interferons in dermatomyositis in vitro","volume":"137","author":"Robinson","year":"2017","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.revmed.2026.06.013_bib0615","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13075-021-02665-x","article-title":"Cannabinoid type 2 receptor (CB2R) distribution in dermatomyositis skin and peripheral blood mononuclear cells (PBMCs) and in vivo effects of Lenabasum(TM)","volume":"24","author":"Maddukuri","year":"2022","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.revmed.2026.06.013_bib0620","first-page":"100311","article-title":"Long-term safety and efficacy of lenabasum, a cannabinoid receptor type 2 agonist, in patients with dermatomyositis with refractory skin disease: follow-up data from a 3-year open-label extension study","volume":"5","author":"Stone","year":"2025","journal-title":"JID Innov Skin Sci Mol Popul Health"},{"key":"10.1016\/j.revmed.2026.06.013_bib0625","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1016\/j.jid.2022.03.029","article-title":"Safety and efficacy of lenabasum, a cannabinoid receptor type 2 agonist, in patients with dermatomyositis with refractory skin disease: a randomized clinical trial","volume":"142","author":"Werth","year":"2022","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.revmed.2026.06.013_bib0630","doi-asserted-by":"crossref","first-page":"17232","DOI":"10.1038\/s41598-025-92001-z","article-title":"Diverse Lenabasum pathway activation in dermatomyositis patients\u2019 blood","volume":"15","author":"Kodali","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.revmed.2026.06.013_bib0635","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1007\/s10067-018-4217-9","article-title":"Study of cannabinoid receptor 2 Q63R gene polymorphism in Lebanese patients with rheumatoid arthritis","volume":"37","author":"Ismail","year":"2018","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.revmed.2026.06.013_bib0640","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3109\/03009742.2015.1020863","article-title":"Association between cannabinoid receptor type 2 Q63R variant and oligo\/polyarticular juvenile idiopathic arthritis","volume":"44","author":"Bellini","year":"2015","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.revmed.2026.06.013_bib0645","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1189\/jlb.0205111","article-title":"Reduced endocannabinoid immune modulation by a common cannabinoid 2 (CB2) receptor gene polymorphism: possible risk for autoimmune disorders","volume":"78","author":"Sipe","year":"2005","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.revmed.2026.06.013_bib0650","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/rheumatology\/kei183","article-title":"Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis","volume":"45","author":"Blake","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.revmed.2026.06.013_bib0655","doi-asserted-by":"crossref","first-page":"e028197","DOI":"10.1136\/bmjopen-2018-028197","article-title":"Efficacy and safety of cannabidiol followed by an open label add-on of tetrahydrocannabinol for the treatment of chronic pain in patients with rheumatoid arthritis or ankylosing spondylitis: protocol for a multicentre, randomised, placebo-controlled study","volume":"9","author":"Hendricks","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.revmed.2026.06.013_bib0660","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1097\/j.pain.0000000000002466","article-title":"Cannabidiol treatment in hand osteoarthritis and psoriatic arthritis: a randomized, double-blind, placebo-controlled trial","volume":"163","author":"Vela","year":"2022","journal-title":"Pain"},{"key":"10.1016\/j.revmed.2026.06.013_bib0665","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000332079","article-title":"Impact of cannabis treatment on the quality of life, weight and clinical disease activity in inflammatory bowel disease patients: a pilot prospective study","volume":"85","author":"Lahat","year":"2012","journal-title":"Digestion"},{"key":"10.1016\/j.revmed.2026.06.013_bib0670","first-page":"455","article-title":"Treatment of Crohn's disease with cannabis: an observational study","volume":"13","author":"Naftali","year":"2011","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.revmed.2026.06.013_bib0675","first-page":"CD012954","article-title":"Cannabis for the treatment of ulcerative colitis","volume":"11","author":"Kafil","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.revmed.2026.06.013_bib0340","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1080\/17474124.2024.2443574","article-title":"UK medical cannabis registry: an updated analysis of clinical outcomes of cannabis-based medicinal products for inflammatory bowel disease","volume":"18","author":"Gupta","year":"2024","journal-title":"Expert Rev Gastroenterol Hepatol"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866326006387?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866326006387?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:41:58Z","timestamp":1788482518000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866326006387"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":68,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0248866326006387"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2026.06.013","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Revue de la litt\u00e9rature des effets cliniques immunomodulateurs des cannabino\u00efdes au cours des maladies auto-immunes en m\u00e9decine interne","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2026.06.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI).","name":"copyright","label":"Copyright"}]}}